SCHEMBL17038501

SCHEMBL17038501

C[SiH]1c2ccccc2N(c2ccc(-c3nc4ccccc4s3)cc2)c2ccccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.57
NPC1 O15118 5/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
PKM P14618 2/20 0.57
KMT2A Q03164 2/20 0.57
NPSR1 Q6W5P4 1/20 0.57
APP P05067 8/20 0.50
KDM4E B2RXH2 4/20 0.50
MAPT P10636 3/20 0.50
GLA P06280 2/20 0.50
GAA P10253 2/20 0.50
MMP9 P14780 2/20 0.50
MMP8 P22894 2/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
MEN1 O00255 1/20 0.50
PAX8 Q06710 1/20 0.50
NOD2 Q9HC29 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
TNF P01375 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30665633 0.86 RAB9A (0.69) RAB9ANPC1SMN1; SMN2PKMKMT2A
SCHEMBL17879373 0.86 RAB9A (0.69) RAB9ANPC1SMN1; SMN2PKMKMT2A
SCHEMBL17038497 0.84 RAB9A (0.66) RAB9ANPC1SMN1; SMN2PKMKMT2A
SCHEMBL6023528 0.82 RAB9A (0.64) RAB9ANPC1SMN1; SMN2PKMKMT2A
SCHEMBL29528535 0.82 RAB9A (0.60) RAB9ANPC1SMN1; SMN2PKMKMT2A
SCHEMBL17038509 0.80 RAB9A (0.61) RAB9ANPC1SMN1; SMN2PKMKMT2A
SCHEMBL20383137 0.80 RAB9A (0.57) RAB9ANPC1SMN1; SMN2PKMKMT2A
SCHEMBL20383153 0.80 RAB9A (0.57) RAB9ANPC1SMN1; SMN2PKMKMT2A
SCHEMBL17038508 0.80 RAB9A (0.57) RAB9ANPC1SMN1; SMN2PKMKMT2A
SCHEMBL17038495 0.79 RAB9A (0.60) RAB9ANPC1SMN1; SMN2PKMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210074927-A1 ORGANIC ELECTROLUMINESCENT DEVICE KYULUX, INC. (JP) 2021-03-11 US disclosed
US-20170213974-A1 ORGANIC LIGHT-EMITTING DEVICE, HOST MATERIAL, LIGHT-EMITTING MATERIAL, AND COMPOUND KYULUX, INC. (JP) 2017-07-27 US disclosed
US-20170213974-A1 ORGANIC LIGHT-EMITTING DEVICE, HOST MATERIAL, LIGHT-EMITTING MATERIAL, AND COMPOUND KYULUX, INC. (JP) 2017-07-27 US disclosed
US-20170163010-A1 ORGANIC LIGHT-EMITTING ELEMENT KYUSHU UNIVERSITY NATIONAL UNIVERSITY CORPORATION (JP) 2017-06-08 US disclosed
US-20170163010-A1 ORGANIC LIGHT-EMITTING ELEMENT KYUSHU UNIVERSITY NATIONAL UNIVERSITY CORPORATION (JP) 2017-06-08 US disclosed
US-20160190478-A1 ORGANIC ELECTROLUMINESCENT DEVICE KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2016-06-30 US disclosed
US-20160190478-A1 ORGANIC ELECTROLUMINESCENT DEVICE KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2016-06-30 US disclosed
US-20150239880-A1 LIGHT EMITTING MATERIAL, COMPOUND, AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME UNIV KYUSHU NAT UNIV CORP (JP) 2015-08-27 US disclosed
US-20150239880-A1 LIGHT EMITTING MATERIAL, COMPOUND, AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME UNIV KYUSHU NAT UNIV CORP (JP) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239880-A1 LIGHT EMITTING MATERIAL, COMPOUND, AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME RER1, NR2E3, CRY1 RAB9A 2041/4885NPC1 2873/4885SMN1; SMN2 1678/4885
US-20170213974-A1 ORGANIC LIGHT-EMITTING DEVICE, HOST MATERIAL, LIGHT-EMITTING MATERIAL, AND COMPOUND CRY1, CRY2, CYBA RAB9A 4082/4885NPC1 3146/4885SMN1; SMN2 3376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.